Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.1M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
9.96M
-
Shares change
-
+562K
-
Total reported value, excl. options
-
$7.25M
-
Value change
-
+$283K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$0.73
Significant Holders of BiomX Inc. - Common Stock (PHGE) as of Q4 2024
19 filings reported holding PHGE - BiomX Inc. - Common Stock as of Q4 2024.
BiomX Inc. - Common Stock (PHGE) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.96M shares
of 26.1M outstanding shares and own 38.14% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1.79M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.79M shares), Nantahala Capital Management, LLC (1.73M shares), Ikarian Capital, LLC (893K shares), Alyeska Investment Group, L.P. (865K shares), AIGH Capital Management LLC (865K shares), Allostery Investments LP (644K shares), JPMORGAN CHASE & CO (430K shares), DAFNA Capital Management LLC (401K shares), and HEIGHTS CAPITAL MANAGEMENT, INC (258K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.